Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines

Nonviral Gene Delivery to Neural Stem Cells with Minicircles by Microporation

(2013) Catarina Madeira et al.   BIOMACROMOLECULES

DNA vaccines against viral diseases of farmed fish

(2013) Øystein Evensen et al.   FISH & SHELLFISH IMMUNOLOGY

Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection

(2013) Jamie F.S. Mann et al.   JOURNAL OF CONTROLLED RELEASE

Intracellular Tracking of Single-plasmid DNA Particles After Delivery by Electroporation

(2013) Christelle Rosazza et al.   MOLECULAR THERAPY

Mucosal Application of gp140 Encoding DNA Polyplexes to Different Tissues Results in Altered Immunological Outcomes in Mice

(2013) Jamie F. S. Mann et al.   PLoS One

Transposon leads to contamination of clinical pDNA vaccine

(2013) I. van der Heijden et al.   VACCINE

A DNA-Based Candidate HIV Vaccine Delivered viaIn VivoElectroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers

(2012) Jakub Kopycinski et al.   Clinical and Vaccine Immunology

Clinical Applications of DNA Vaccines: Current Progress

(2011) B. Ferraro et al.   CLINICAL INFECTIOUS DISEASES

Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms

(2011) Louise Donnelly et al.   VACCINE

Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction

(2011) Xin Huang et al.   VIROLOGY

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

(2011) Natalie A Hutnick et al.   Current Opinion in Virology

Targeted minicircle DNA delivery using folate–poly(ethylene glycol)–polyethylenimine as non-viral carrier

(2010) Chao Zhang et al.   BIOMATERIALS

Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers

(2010) J M Luke et al.   GENE THERAPY

DNA vaccines: an historical perspective and view to the future

(2010) Margaret A. Liu   IMMUNOLOGICAL REVIEWS

Marker-free plasmids for gene therapeutic applications—Lack of antibiotic resistance gene substantially improves the manufacturing process

(2010) Jürgen Mairhofer et al.   JOURNAL OF BIOTECHNOLOGY

Genetic Susceptibility to the Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Is MHC Dependent

(2010) J. S. Tregoning et al.   JOURNAL OF IMMUNOLOGY

A robust system for production of minicircle DNA vectors

(2010) Mark A Kay et al.   NATURE BIOTECHNOLOGY

Immune response induced by a linear DNA vector: Influence of dose, formulation and route of injection

(2010) Anne Endmann et al.   VACCINE

Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system

(2009) Jeremy Luke et al.   VACCINE

FDA guidance on prophylactic DNA vaccines: Analysis and recommendations

(2009) Dennis M. Klinman et al.   VACCINE